Localization patterns of cathepsins K and X and their predictive value in glioblastoma
References
- Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016; 131: 803-20. 10.1007/s00401-016-1545-1
- Czarnek N, Clark K, Peters KB, Mazurowski MA. Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study. J Neurooncol 2017; 132: 55-62. 10.1007/s11060-016-2359-7
- Cuddapah VA, Robel S, Watkins S, Sontheimer H. A neurocentric perspective on glioma invasion. Nat Rev Neurosci 2014; 15: 455-65. 10.1038/ nrn3765
- Roos A, Ding Z, Loftus JC, Tran NL. Molecular and microenvironmental determinants of glioma stem-like cell survival and invasion. Front Oncol 2017; 7: 120. 10.3389/fonc.2017.00120
- Mentlein R, Hattermann K, Held-Feindt J. Lost in disruption: role of proteases in glioma invasion and progression. Biochim Biophys Acta 2012; 1825: 178-85. 10.1016/j.bbcan.2011.12.001
- Colin, C, Voutsinos-Porche B, Nanni I, Fina F, Metellus P, Intagliata D, et al. High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas. Acta Neuropathol 2009; 118: 745-54. 10.1007/s00401-009-0592-2
- Gole B, Huszthy PC, Popović M, Jeruc J, Ardebili YS, Bjerkvig R, et al. The regulation of cysteine cathepsins and cystatins in human gliomas. Int J Cancer 2012; 131: 1779-89. 10.1002/ijc.27453
- Olson OC, Joyce JA. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. Nat Rev Cancer 2015; 15: 712-29. 10.1038/nrc4027
- Kenig S, Frangež R, Pucer A, Lah T. Inhibition of cathepsin L lowers the apoptotic threshold of glioblastoma cells by up-regulating p53 and transcription of caspases 3 and 7. Apoptosis 2011; 16: 671-82. 10.1007/s10495-011-0600-6
- Lankelma JM, Voorend DM, Barwari T, Koetsveld J, Van der Spek AH, De Porto AP, et al. Cathepsin L, target in cancer treatment? Life Sci 2010; 86: 225-33. 10.1016/j.lfs.2009.11.016
- Breznik B, Motaln H, Turnšek TL. Proteases and cytokines as mediators of interactions between cancer and stromal cells in tumours. Biol Chem 2017; 398: 709-19. 10.1515/hsz-2016-0283
- Kramer L, Turk D, Turk B. The future of cysteine cathepsins in disease management. Trends Pharmacol Sci 2017; 38: 873-98. 10.1016/j. tips.2017.06.003
- López-Otín C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007; 7: 800-8. 10.1038/nrc2228
- Quail DF, Joyce JA. The microenvironmental landscape of brain tumors. Cancer Cell 2017; 31: 326-41. 10.1016/j.ccell.2017.02.009
- Lah TT, Duran Alonso MB, Van Noorden CF. Antiprotease therapy in cancer: hot or not? Expert Opin Biol Ther 2006; 6: 257-79. 10.1517/14712598.6.3.257
- Lah TT, Obermajer N, Duran Alonso MB, Kos J. Cysteine cathepsins and cystatins as cancer biomarkers. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF, editors. The cancer degradome: proteases and cancer biology New York: Springer; 2008. p. 575-613.
- Flannery T, McQuaid S, McGoohan C, McConnell RS, McGregor G, Mirakhur M, et al. Cathepsin S expression: an independent prognostic factor in glioblastoma tumours - a pilot study. Int J Cancer 2006; 119: 854-60. 10.1002/ijc.21911
- Verbovšek U, Motaln H, Rotter A, Atai NA, Gruden K, Van Noorden CJ, et al. Expression analysis of all protease genes reveals cathepsin K to be overexpressed in glioblastoma PLoS One 2014; 9: e111819. 10.1371/ journal.pone.0111819
- Verbovšek U, Van Noorden CJ, Lah TT. Complexity of cancer protease biology: cathepsin K expression and function in cancer progression. Semin Cancer Biol 2015; 35: 71-84. 10.1016/j.semcancer.2015.08.010
- Novinec M, Lenarčič B. Cathepsin K: a unique collagenolytic cysteine peptidase. Biol Chem 2013; 394: 1163-79. 10.1515/hsz-2013-0134
- Staudt ND, Maurer A, Spring B, Kalbacher H, Aicher WK, Klein G. Processing of CXCL12 by different osteoblast-secreted cathepsins. Stem Cells Dev 2012; 21: 1924-35. 10.1089/scd.2011.0307
- Hira VV, Verbovšek U, Breznik B, Srdič M, Novinec M, Kakar H, et al. Cathepsin K cleavage of SDF-1α inhibits its chemotactic activity towards glioblastoma stem-like cells. Biochim Biophys Acta 2017; 1864: 594-603. 10.1016/j.bbamcr.2016.12.021
- Kos J, Vižin T, Fonović UP, Pišlar A. Intracellular signaling by cathepsin X: molecular mechanisms and diagnostic and therapeutic opportunities in cancer. Semin Cancer Biol 2015; 31: 76-83. 10.1016/j.semcancer.2014.05.001
- Kos J, Jevnikar Z, Obermajer N. The role of cathepsin X in cell signaling. Cell Adh Migr 2009; 3: 164-6.
- Wendt W, Zhu XR, Lübbert H, Stichel CC. Differential expression of cathepsin X in aging and pathological central nervous system of mice. Exp Neurol 2007; 204: 525-40. 10.1016/j.expneurol.2007.01.007
- Nägler DK, Krüger S, Kellner A, Ziomek E, Menard R, Buhtz P, et al. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia. Prostate 2004; 60: 109-19. 10.1002/pros.20046
- Krueger S, Kalinski T, Hundertmark T, Wex T, Küster D, Peitz U, et al. Up-regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer. J Pathol 2005; 207: 32-42. 10.1002/path.1820
- Vizin T, Christensen IJ, Nielsen HJ, Kos J. Cathepsin X in serum from patients with colorectal cancer: relation to prognosis. Radiol Oncol 2012; 46: 207-12. 10.2478/v10019-012-0040-0
- Gopinath S, Malla R, Alapati K, Gorantla B, Gujrati M, Dinh DH, et al. Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression. Carcinogenesis 2013; 34: 550-9. 10.1093/carcin/bgs375
- Alapati K, Kesanakurti D, Rao JS, Dasari VR. uPAR and cathepsin B-mediated compartmentalization of JNK regulates the migration of glioma-initiating cells. Stem Cell Res 2014; 12: 716-29. 10.1016/j.scr.2014.02.008
- Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN. Cancer stem cells in glioblastoma. Genes Dev 2015; 29: 1203-17. 10.1101/ gad.261982.115
- Godlewski J, Ferrer-Luna R, Rooj AK, Mineo M, Ricklefs F, Takeda YS, et al. MicroRNA Signatures and molecular subtypes of glioblastoma: the role of extracellular transfer. Stem Cell Reports 2017; 8: 1497-505. 10.1016/j. stemcr.2017.04.024
- Hira VV, Ploegmakers KJ, Grevers F, Verbovšek U, Silvestre-Roig C, Aronica E, et al. CD133+ and nestin+ glioma stem-like cells reside around CD31+ arterioles in niches that express SDF-1α, CXCR4, osteopontin and cathepsin K. J Histochem Cytochem 2015; 63: 481-93. 10.1369/0022155415581689
- Hira VVV, Aderetti DA, van Noorden CJF. Glioma stem cell niches in human glioblastoma are periarteriolar. J Histochem Cytochem 2018; 66: 349-58. 10.1369/0022155417752676
- Hira VVV, Wormer JR, Kakar H, Breznik B, van der Swaan B, Hulsbos R, et al. Periarteriolar glioblastoma stem cell niches express bone marrow hematopoietic stem cell niche proteins. J Histochem Cytochem 2018; 66: 155-73. 10.1369/0022155417749174
- GlioVis: Data visualization tools for brain tumor datasets. 2017. [citated 20 Sep 2017]. Available from: http://gliovis.bioinfo.cnio.es/
- Bowman RL, Wang Q, Carro A, Verhaak RG, Squatrito M. GlioVis data portal for visualization and analysis of brain tumor expression datasets. Neuro Oncol 2017; 19: 139-41. 10.1093/neuonc/now247
- Završnik J, Butinar M, Trstenjak Prebanda M, Krajnc A, Vidmar R, Fonović M, et al. Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells. Oncotarget 2017; 8: 73793-809. 10.18632/oncotarget.17379
- Chieco P, Jonker A, De Boer BA, Ruijter JM, Van Noorden CJ. Image cytometry: protocols for 2D and 3D quantification in microscopic images. Prog Histochem Cytochem 2013; 47: 211-333. 10.1016/j.proghi.2012.09.001
- Segerman A, Niklasson M, Haglund C, Bergström T, Jarvius M, Xie Y, et al. Clonal variation in drug and radiation response among glioma-initiating cells is linked to proneural-mesenchymal transition. Cell Rep 2016; 17: 29943009. 10.1016/j.celrep.2016.11.056
- Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al; Cancer Genome Atlas Research Network. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010; 17: 98-110. 10.1016/j.ccr.2009.12.020
- Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, et al. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 2008; 14: 123-9. 10.1158/1078-0432.CCR-07-0932
- Kenig S, Alonso MB, Mueller MM, Lah TT. Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9. Cancer Lett 2010; 289: 53-61. 10.1016/j.canlet.2009.07.014
- Plaks V, Kong N, Werb Z. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell 2015; 16: 225-38. 10.1016/j.stem.2015.02.015
- Saito K, Hirai T, Takeshima H, Kadota Y, Yamashita S, Ivanova A, Yokogami K. Genetic factors affecting intraoperative 5-aminolevulinic acid-induced fluorescence of diffuse gliomas. Radiol Oncol 2017; 51:142-50. 10.1515/ raon-2017-0019
- Strojnik T, Kos J, Zidanik B, Golouh R, Lah T. Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors. Clin Cancer Res 1999; 5: 559-67.
- Strojnik T, Kavalar R, Trinkaus M, Lah TT. Cathepsin L in glioma progression: comparison with cathepsin B. Cancer Detect Prev 2005; 29: 448-55. 10.1016/j.cdp.2005.07.006
- Dauth S, Schmidt MM, Rehders M, Dietz F, Kelm S, Dringen R, et al. Characterisation and metabolism of astroglia-rich primary cultures from cathepsin K-deficient mice. Biol Chem 2012; 393: 959-70. 10.1515/ hsz-2012-0145
- Dauth S, Sîrbulescu RF, Jordans S, Rehders M, Avena L, Oswald J, et al. Cathepsin K deficiency in mice induces structural and metabolic changes in the central nervous system that are associated with learning and memory deficits. BMC Neurosci 2011; 12: 74. 10.1186/1471-2202-12-74
- Wang J, Chen L, Li Y, Guan XY. Overexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. PLoS One 2011; 6: e24967. 10.1371/journal. pone.0024967
- Sevenich L, Schurigt U, Sachse K, Gajda M, Werner F, Müller S, et al. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. Proc Natl Acad Sci US A 2010; 107: 2497-502. 10.1073/pnas.0907240107
- Mitrović A, Pečar Fonović U, Kos J. Cysteine cathepsins B and X promote epithelial-mesenchymal transition of tumor cells. Eur J Cell Biol 2017; 96: 622-31. 10.1016/j.ejcb.2017.04.003
- Akkari L, Gocheva V, Kester JC, Hunter KE, Quick ML, Sevenich L, et al. Distinct functions of macrophage-derived and cancer cell-derived cathepsin Z combine to promote tumor malignancy via interactions with the extracellular matrix. Genes Dev 2014; 28: 2134-50. 10.1101/gad.249599.114
- Euskirchen P, Radke J, Schmidt MS, Schulze Heuling E, Kadikowski E, Maricos M, et al. Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma. PLoS One 2017; 12: e0185376. 10.1371/journal.pone.0185376
- Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007; 11: 69-82. 10.1016/j.ccr.2006.11.020
- Zhu TS, Costello MA, Talsma CE, Flack CG, Crowley JG, Hamm LL, et al. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res 2011; 71: 6061-72. 10.1158/0008-5472.CAN-10-4269
- Goffart N, Lombard A, Lallemand F, Kroonen J, Nassen J, Di Valentin E, et al. CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone. Neuro Oncol 2017; 19: 66-77. 10.1093/neuonc/now136
- Ardebili SY, Zajc I, Gole B, Campos B, Herold-Mende C, Drmota S, et al. CD133/prominin1 is prognostic for GBM patient’s survival, but inversely correlated with cysteine cathepsins’ expression in glioblastoma derived spheroids. Radiol Oncol 2011; 45: 102-15. 10.2478/v10019-011-0015-6
- Kollet O, Dar A, Shivtiel S, Kalinkovich A, Lapid K, Sztainberg Y, et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 2006 ;12: 657–64. 10.1038/ nm1417
- MEROPS database: The peptidase database. [15 Dec 2017]. Citated https://www.ebi.ac.uk/merops/index.shtml.
Language: English
Page range: 433 - 442
Submitted on: May 23, 2018
Accepted on: Sep 11, 2018
Published on: Oct 18, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2018 Barbara Breznik, Clara Limback, Andrej Porcnik, Andrej Blejec, Miha Koprivnikar Krajnc, Roman Bosnjak, Janko Kos, Cornelis J.F. Van Noorden, Tamara T. Lah, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.